Show
Sort by
-
- Journal Article
- A1
- open access
Real-world effectiveness of ocrelizumab in relapsing multiple sclerosis : an MSBase registry sub-study
-
Moderate–high efficacy disease-modifying therapies reduce relapse risk in late-onset multiple sclerosis
-
- Journal Article
- A1
- open access
Progression independent of relapse activity and relapse-associated worsening in seronegative NMOSD : an international cohort study
-
Corticosteroid treatment of multiple sclerosis relapses is associated with lower disability worsening over 5 years
-
- Journal Article
- A1
- open access
Managing reactivation of multiple sclerosis during treatment with natalizumab
-
- Journal Article
- A2
- open access
Persistent progression independent of relapse activity in multiple sclerosis
-
- Journal Article
- A1
- open access
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis
-
- Journal Article
- A1
- open access
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data
-
- Journal Article
- A1
- open access
Four years on : pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)
-
- Journal Article
- A1
- open access
Pregnancy-related disease outcomes in women with moderate to severe multiple sclerosis disability